These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32589056)

  • 1. Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial.
    Garcia CJ; Haynes K; Pokorney SD; Lin ND; McMahill-Walraven C; Nair V; Parlett L; Martin D; Al-Khalidi HR; McCall D; Granger CB; Platt R; Cocoros NM
    Clin Trials; 2020 Aug; 17(4):360-367. PubMed ID: 32589056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA-Catalyst-Using FDA's Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial.
    Cocoros NM; Pokorney SD; Haynes K; Garcia C; Al-Khalidi HR; Al-Khatib SM; Archdeacon P; Goldsack JC; Harkins T; Lin ND; Martin D; McCall D; Nair V; Parlett L; Temple R; McMahill-Walraven C; Granger CB; Platt R
    Clin Trials; 2019 Feb; 16(1):90-97. PubMed ID: 30445835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
    Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
    JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
    Vinereanu D; Lopes RD; Bahit MC; Xavier D; Jiang J; Al-Khalidi HR; He W; Xian Y; Ciobanu AO; Kamath DY; Fox KA; Rao MP; Pokorney SD; Berwanger O; Tajer C; de Barros E Silva PGM; Roettig ML; Huo Y; Granger CB;
    Lancet; 2017 Oct; 390(10104):1737-1746. PubMed ID: 28859942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.
    Kapoor A; Amroze A; Vakil F; Crawford S; Der J; Mathew J; Alper E; Yogaratnam D; Javed S; Elhag R; Lin A; Narayanan S; Bartlett D; Nagy A; Shagoury BK; Fischer MA; Mazor KM; Saczynski JS; Ashburner JM; Lopes R; McManus DD
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005871. PubMed ID: 32063041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren't so simple.
    Cocoros NM; Gurwitz JH; Cziraky MJ; Granger CB; Harkins T; Haynes K; Li X; Parlett L; Seeger JD; Singh S; McMahill-Walraven CN; Platt R
    Clin Trials; 2023 Aug; 20(4):416-424. PubMed ID: 37322894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health.
    Ma Q; Chung H; Shambhu S; Roe M; Cziraky M; Jones WS; Haynes K
    Clin Trials; 2019 Aug; 16(4):419-430. PubMed ID: 31081367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.
    Weinfurt KP; Hernandez AF; Coronado GD; DeBar LL; Dember LM; Green BB; Heagerty PJ; Huang SS; James KT; Jarvik JG; Larson EB; Mor V; Platt R; Rosenthal GE; Septimus EJ; Simon GE; Staman KL; Sugarman J; Vazquez M; Zatzick D; Curtis LH
    BMC Med Res Methodol; 2017 Sep; 17(1):144. PubMed ID: 28923013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients.
    Li XS; Deitelzweig S; Keshishian A; Hamilton M; Horblyuk R; Gupta K; Luo X; Mardekian J; Friend K; Nadkarni A; Pan X; Lip GYH
    Thromb Haemost; 2017 Jun; 117(6):1072-1082. PubMed ID: 28300870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients.
    Coleman CI; Vaitsiakhovich T; Nguyen E; Weeda ER; Sood NA; Bunz TJ; Schaefer B; Meinecke AK; Eriksson D
    Clin Cardiol; 2018 Jan; 41(1):119-125. PubMed ID: 29360144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated medical cost reductions associated with apixaban in real-world patients with non-valvular atrial fibrillation.
    Amin A; Stokes M; Wu N; Gatt E; Makenbaeva D; Wiederkehr D; Boulanger L
    J Med Econ; 2013 Oct; 16(10):1193-202. PubMed ID: 23883416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of health plan administrative claims data in participant recruitment for pragmatic clinical trials: An Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) example.
    Shi Q; Shambhu S; Marshall A; Rose-Kennedy E; Robertson H; Paullin M; Jones WS; Cziraky M; Haynes K
    Clin Trials; 2020 Apr; 17(2):212-222. PubMed ID: 32009464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.
    Hohnloser SH; Fudim M; Alexander JH; Wojdyla DM; Ezekowitz JA; Hanna M; Atar D; Hijazi Z; Bahit MC; Al-Khatib SM; Lopez-Sendon JL; Wallentin L; Granger CB; Lopes RD
    Circulation; 2019 May; 139(20):2292-2300. PubMed ID: 30773022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.
    van den Dries CJ; Oudega R; Elvan A; Rutten FH; van de Leur SJCM; Bilo HJG; Hoes AW; Moons KGM; Geersing GJ
    BMJ Open; 2017 Sep; 7(9):e015510. PubMed ID: 28928175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient population.
    Amin A; Stokes M; Makenbaeva D; Wiederkehr D; Wu N; Lawrence JH
    J Med Econ; 2014 Nov; 17(11):771-81. PubMed ID: 25133458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
    Carnicelli AP; Hong H; Giugliano RP; Connolly SJ; Eikelboom J; Patel MR; Wallentin L; Morrow DA; Wojdyla D; Hua K; Hohnloser SH; Oldgren J; Ruff CT; Piccini JP; Lopes RD; Alexander JH; Granger CB;
    Am Heart J; 2021 Mar; 233():48-58. PubMed ID: 33296688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.
    Yoon CH; Park YK; Kim SJ; Lee MJ; Ryoo S; Kim GM; Chung CS; Lee KH; Kim JS; Bang OY
    Stroke; 2014 Oct; 45(10):2983-8. PubMed ID: 25147329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial.
    Matchar DB; Samsa GP; Cohen SJ; Oddone EZ; Jurgelski AE
    Am J Med; 2002 Jul; 113(1):42-51. PubMed ID: 12106622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.